Osteosarcoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}[[User:DrMars|Mohammadmain Rezazadehsaatlou[2]]]. | {{CMG}}; {{AE}}[[User:DrMars|Mohammadmain Rezazadehsaatlou[2]]]. | ||
==Overview== | ==Overview== | ||
Laboratory tests for osteosarcoma include complete blood count (CBC), serum [[alkaline phosphatase]] and [[lactate dehydrogenase]]. | Laboratory tests for [[osteosarcoma]] include [[complete blood count]] ([[Complete blood count|CBC]]), serum [[alkaline phosphatase]] and [[lactate dehydrogenase]]. | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
Revision as of 13:16, 17 October 2019
|
Osteosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteosarcoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Osteosarcoma laboratory findings |
|
Risk calculators and risk factors for Osteosarcoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
Overview
Laboratory tests for osteosarcoma include complete blood count (CBC), serum alkaline phosphatase and lactate dehydrogenase.
Laboratory Tests
Laboratory tests for osteosarcoma include the following:[1][2][3][4][5]
- Complete blood count (CBC), including differential
- Platelet count
- Liver function tests - Aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, and albumin
- Electrolyte levels - Sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphorus
- Renal function tests - Blood urea nitrogen (BUN), creatinine
- Urinalysis
- Blood chemistry studies include:
References
- ↑ Kim HJ, Chalmers PN, Morris CD (February 2010). "Pediatric osteogenic sarcoma". Curr. Opin. Pediatr. 22 (1): 61–6. doi:10.1097/MOP.0b013e328334581f. PMID 19915470.
- ↑ Moore DD, Luu HH (2014). "Osteosarcoma". Cancer Treat. Res. 162: 65–92. doi:10.1007/978-3-319-07323-1_4. PMID 25070231.
- ↑ Ilaslan H, Schils J, Nageotte W, Lietman SA, Sundaram M (March 2010). "Clinical presentation and imaging of bone and soft-tissue sarcomas". Cleve Clin J Med. 77 Suppl 1: S2–7. doi:10.3949/ccjm.77.s1.01. PMID 20179183.
- ↑ Wu PK, Chen WM, Lee OK, Chen CF, Huang CK, Chen TH (November 2010). "The prognosis for patients with osteosarcoma who have received prior manipulative therapy". J Bone Joint Surg Br. 92 (11): 1580–5. doi:10.1302/0301-620X.92B11.24706. PMID 21037356.
- ↑ Obiedat H, Alrabadi N, Sultan E, Al Shatti M, Zihlif M (July 2018). "The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients". BMC Med. Genet. 19 (1): 112. doi:10.1186/s12881-018-0627-4. PMC 6035436. PMID 29980176.